Non-Executive Director Thomas Ramdahl Just Bought A Handful Of Shares In Clarity Pharmaceuticals Ltd (ASX:CU6)
yahoo.com
news
2022-06-02 20:17:30

Whilst it may not be a huge deal, we thought it was good to see that the Clarity Pharmaceuticals Ltd (ASX:CU6) Non-Executive Director, Thomas Ramdahl, recently bought AU$58k worth of stock, for AU$0.48 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.

Check out our latest analysis for Clarity Pharmaceuticals

Clarity Pharmaceuticals Insider Transactions Over The Last Year

Notably, that recent purchase by Thomas Ramdahl is the biggest insider purchase of Clarity Pharmaceuticals shares that we've seen in the last year.
